Position in INSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$132,445,709
+$93,688,690 QoQ
Shares Held
1,242,222
+424.1% QoQ
Ownership
0.569%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#37
of 665 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Derivatives in INSM
reported options exposure · as of Jun 30, 2026CallValue
$586,410
CallShares
5,500
PutValue
$266,550
PutShares
2,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. INSM ranks #15 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in INSM
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $586,410 | 5,500 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $266,550 | 2,500 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $132,445,709 | 1,242,222 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $38,757,019 | 237,017 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $167,453,630 | 962,156 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $111,288,047 | 772,780 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $37,891,765 | 376,508 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $31,042,629 | 406,903 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $41,009,483 | 593,996 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $58,483,147 | 801,139 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,218,848 | 107,744 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $12,484,493 | 460,173 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $10,927,445 | 352,612 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $15,002,540 | 594,160 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,313,089 | 488,772 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,787,076 | 456,720 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $9,091,619 | 455,036 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,389,194 | 296,620 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $653,300 | 27,800 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $749,100 | 27,500 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $9,231,655 | 335,209 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,773,422 | 273,135 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,648,070 | 224,547 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $453,942 | 13,636 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $6,941,018 | 215,962 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $4,359,334 | 158,291 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $746,276 | 46,555 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||